📋 Case Overview

| | |

|---|---|

| Article Type | Roundup |

| Vertical | False Advertising / Consumer Protection |

| Cases Covered | 3 |

| Date Published | March 2026 |

False Advertising Cases to Watch: Lenovo Texts, Cord Blood Claims, and a Class Certification Setback

Three consumer protection developments from the past week offer a snapshot of where false advertising litigation stands heading into spring 2026 — from a tech giant accused of ignoring text messaging laws to state attorneys general taking on a cord blood storage company, to a federal court decision that serves as a cautionary tale for class action plaintiffs.

Here's what you need to know.

1. Lenovo Accused of Sending Marketing Texts at Unlawful Hours

Case Status: Newly Filed

Who May Be Affected: Consumers who received Lenovo marketing text messages outside legally permitted hours

Legal Basis: Alleged violations of state telemarketing and consumer protection statutes

According to a recent class action filing, a new lawsuit alleges that Lenovo United States Inc. sent promotional text messages to consumers at hours prohibited under applicable telemarketing laws. The complaint claims the company's outreach fell outside the time windows that regulators have established to protect consumers from unwanted contact.

The lawsuit alleges that affected recipients did not consent to receive messages at those hours, and that Lenovo's alleged conduct constitutes a pattern of unlawful communication rather than an isolated incident. The plaintiff is seeking to represent a class of consumers who received similar texts.

Federal and state telemarketing rules generally restrict outbound marketing calls and texts to specific daytime windows — typically between 8 a.m. and 9 p.m. in the recipient's local time zone. Violations can carry statutory damages per message, which is why these cases are frequently pursued as class actions.

Lenovo has not yet publicly responded to the allegations. The lawsuit was filed in connection with conduct the plaintiff says affected a broad population of consumers.

What to know: Consumers who believe they received marketing texts from Lenovo outside permitted hours may want to document those messages, including timestamps, as the case develops.

2. Two States Sue Cord Blood Registry Over Allegedly Misleading Health Claims

Case Status: State Enforcement Actions Filed

Who May Be Affected: Parents who paid to store newborn cord blood based on advertised health benefits

Legal Basis: State consumer protection and deceptive trade practices statutes

Two state attorneys general have taken legal action against Cord Blood Registry (CBR), one of the country's largest cord blood storage companies, alleging the company misled parents about the medical benefits of preserving their newborn's stem cells.

Texas filed suit against CBR last month, with a second state joining the enforcement effort. The lawsuits allege that CBR marketed cord blood banking as offering significant future medical benefits that current science does not fully support — leading parents to pay substantial storage fees based on allegedly overstated claims.

According to the complaints, CBR's marketing materials suggested a degree of medical certainty around cord blood's therapeutic value that regulators and independent medical organizations have not confirmed. Parents who enrolled in storage plans, the states allege, made financial decisions based on representations that did not accurately reflect the state of the science.

Cord blood storage typically costs families an upfront collection fee of several hundred to over a thousand dollars, plus annual storage fees that can run for decades. If the states' allegations are borne out, affected families may have paid a significant price premium for benefits that were, according to the complaints, overstated.

CBR has not responded publicly to the state lawsuits at the time of publication. The American Academy of Pediatrics has previously noted that private cord blood banking is not recommended for most families as a form of "biological insurance," citing the low likelihood that stored blood will be used.

What to know: Parents who stored cord blood with CBR based on its advertised health claims may want to monitor these cases as they proceed through the courts.

3. Court Rejects Blue Diamond "Smoked Almonds" Class — A Warning for Future Plaintiffs

Case Status: Class Certification Denied

Case: Clark v. Blue Diamond Growers, N.D. Ill., Feb. 20, 2026

Key Lesson: A named plaintiff's individual circumstances can sink an entire class action before it begins

Not every false advertising lawsuit ends in a settlement or a trial — and a recent federal court decision out of Illinois is a reminder of how individual plaintiff vulnerabilities can derail even seemingly straightforward consumer cases.

In Clark v. Blue Diamond Growers, a federal judge in the Northern District of Illinois denied class certification in a lawsuit alleging that Blue Diamond's "Smoked Almonds" labeling misled consumers into believing the almonds were prepared using a traditional smoking process, when the complaint alleged they were flavored artificially instead.

The court's decision, issued February 20, 2026, turned not on whether the labeling claim was false, but on whether the named plaintiff — the individual suing on behalf of the proposed class — was an adequate representative. According to court documents, pre-certification discovery revealed that the plaintiff had knowledge or circumstances that made her situation arguably unique compared to the broader class of consumers she sought to represent. Under class action rules, a named plaintiff whose case is subject to unique defenses can be disqualified from representing others, since those individual issues would distract from the common questions that must predominate for a class to be certified.

The ruling illustrates a growing defense strategy in false advertising cases: use early discovery to surface facts about the named plaintiff specifically, rather than contesting the merits of the underlying claims. Even if a labeling practice affects thousands of consumers, the case can collapse at the certification stage if the lead plaintiff's credibility or circumstances are called into question.

For consumers and attorneys watching the false advertising space, the Blue Diamond outcome underscores how critical the selection and vetting of named plaintiffs has become in class litigation.

What to know: This ruling does not prevent other consumers from pursuing similar claims — it means this particular class, as constituted, will not proceed. Future plaintiffs in similar cases may face heightened scrutiny during discovery.

Key Takeaways

• Telemarketing law violations are increasingly fertile ground for class actions. Statutory damages per violation make cases like the Lenovo suit attractive even when individual harm is modest.
• State AG enforcement is a growing complement to private litigation. The CBR lawsuits show that state governments are willing to act where individual consumers may lack the resources to sue directly.
• Class certification is a genuine hurdle, not a formality. The Blue Diamond ruling is a reminder that false advertising suits can fail before reaching a jury — often due to facts about the named plaintiff, not the underlying claims.
• Documentation matters. Consumers who believe they've been affected by any of these cases — misleading texts, overstated health claims, or deceptive labeling — should preserve purchase records, marketing materials, and communications while cases develop.

Are you following any of these cases? Have you been affected by the conduct described in these lawsuits? Share your experience in the comments below.

InjuryClaims.com reports on class action litigation and consumer protection developments. Nothing in this article constitutes legal advice. Eligibility for any legal claim can only be determined by a licensed attorney.